Cencora to Buy American Oncology Network in $2.4B Deal
AONC filed a M&A and Partnerships on light trading volume (0.2× avg).
Summary
Cencora agreed to acquire American Oncology Network at a $2.40B enterprise value, including up to $100M in contingent value rights. Cencora will pay $1.70B to lift its AON ownership to 75%, with the remaining 25% rolled over as equity. The deal is expected to be accretive to adjusted diluted EPS in the second year after closing, and Cencora guided FY2026 adjusted diluted EPS of at least $17.9. For AONC, a thinly traded OTC name, this is a takeout that resets the entire investment case; for Cencora it is a bolt-on that deepens its community oncology support business.
At the time of this announcement, AONC was trading at $8.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $366.1M. The 52-week trading range was $0.00 to $14.25. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.